glp 1 derived from The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review | Stem Cell Reviews and Reports The GLP-1 revolution: What UAB

10.1038/ncomms2001 Nat

Front Immunol (2019) 10:2545

In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)

The anticipation is almost always worse than the reality

Taking your unique needs and situation into account, your doctor or nurse practitioner will recommend a dosage that will treat your condition with the fewest possible side effects